PlainRecalls

OriGen Biomedical, Inc.

19 recalls on record · Latest: Feb 21, 2024

Subscribe to new OriGen Biomedical, Inc. recalls (RSS)

Agency notice ledger

Federal filing book OriGen Biomedical, Inc. LIGHT-BOOK · SINGLE-AGENCY

#857 of 14,151 · 19 notices · 0.018% archive

  • BOOK 19 notices
  • RANK #857 of 14,151
  • SHARE 0.018% archive
  • AGENCY FDA Devices (19)
  • CAT medical devices
  • CATS 1 category
  • LATEST Feb 21, 2024
  • PHOTO Abbott

Nearest notice-volume peer: Abbott (0 notice gap)

OriGen Biomedical, Inc. accounts for about 0.018% of the 104,423-notice archive on 19 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

OriGen Biomedical, Inc.'s standing among 14,151 recalling firms

OriGen Biomedical, Inc. ranks 857th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

OriGen Biomedical, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

19 857th of 14151 higher than 13,281 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

OriGen Biomedical, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows OriGen Biomedical, Inc. holds about 0.018% of archive notices alongside 19 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Devices Moderate Feb 21, 2024

Accessory Sets Syringes: 6ml syringe with a female luer with 15cm sealed SCD tubing, REF: RF-T15, and 60ml syringe on a female luer with 15cm sealed SCD tubing, REF: 15-RF60-T

FDA Devices Low Apr 21, 2021

Evolve Cell Culture Bags, part numbers: EV1000N and EV3000N The Evolve bag is made of Ethyl Vinyl Olefin (EVO) and contains no BPA or latex. The bag can be supplied with tubing sets that can include, but are not limited to, the following components: EVA/PVC coextruded tubing, PVC tubing, Yconnectors, needle-free valves, female luers, male luers and/or caps

FDA Devices Moderate Nov 11, 2020

3/8" FloPump, 32mL, (Sterile), REF 6400S, UDI: (01) 081432102013 1, Sterile EO, Rx Only

FDA Devices Critical Jun 12, 2019

ECMO Reinforced Dual Lumen Cannula, Sterile EO, Rx Only, REF: VV28F

FDA Devices Critical Jun 12, 2019

ECMO Reinforced Dual Lumen Cannula, Sterile EO, Rx Only, REF: VV19F

FDA Devices Critical Jun 12, 2019

ECMO Reinforced Dual Lumen Cannula, Sterile EO, Rx Only, REF: VV13F

FDA Devices Critical Jun 12, 2019

ECMO Reinforced Dual Lumen Cannula, Sterile EO, Rx Only, REF: VV23F

FDA Devices Critical Jun 12, 2019

ECMO Reinforced Dual Lumen Cannula, Sterile EO, Rx Only, REF: VV32F

FDA Devices Critical Jun 12, 2019

ECMO Reinforced Dual Lumen Cannula, Sterile EO, Rx Only, REF: VV16F

FDA Devices Critical Nov 14, 2018

REF VV19F Reinforced Dual Lumen Cannula, 19Fr., Sterile EO, DISPOSABLE: DO NOT RE-USE CE 0473 Product Usage: The OriGen RDLC catheter is indicated for use as a single cannula for both venous drainage and arterial re-infusion of blood in the internal jugular vein during extracorporeal life support procedures of six hours or less.

FDA Devices Moderate Oct 24, 2018

Reinforced Dual Lumen Cannula, 32Fr., REF: VV32F, Sterile EO Indications: The OriGen Reinforced Dual Lumen Cannula is indicated for use as a single cannula for both venous drainage and re-infusion of blood in the internal jugular vein during extracorporeal life support procedures.

FDA Devices Moderate Oct 24, 2018

Reinforced Dual Lumen Cannula, 16Fr., REF: VV16F, Sterile EO Indications: The OriGen Reinforced Dual Lumen Cannula is indicated for use as a single cannula for both venous drainage and re-infusion of blood in the internal jugular vein during extracorporeal life support procedures.

FDA Devices Moderate Oct 24, 2018

Reinforced Dual Lumen Cannula, 13Fr., REF: VV13F, Sterile EO; and ECMO Reinforced Dual Lumen Cannula, 13Fr., REF: VV13F, Sterile EO Indications: The OriGen Reinforced Dual Lumen Cannula is indicated for use as a single cannula for both venous drainage and re-infusion of blood in the internal jugular vein during extracorporeal life support procedures.

FDA Devices Moderate Oct 24, 2018

Reinforced Dual Lumen Cannula, 23Fr., REF: VV23F, Sterile EO Indications: The OriGen Reinforced Dual Lumen Cannula is indicated for use as a single cannula for both venous drainage and re-infusion of blood in the internal jugular vein during extracorporeal life support procedures.

FDA Devices Moderate Oct 24, 2018

Reinforced Dual Lumen Cannula, 13Fr., REF: VV13F, Sterile EO; and ECMO Reinforced Dual Lumen Cannula, 13Fr., REF: VV13F, Sterile EO

FDA Devices Moderate Oct 24, 2018

ECMO Reinforced Dual Lumen Cannula, 28Fr., REF: VV28F, Sterile EO Indications: The OriGen Reinforced Dual Lumen Cannula is indicated for use as a single cannula for both venous drainage and re-infusion of blood in the internal jugular vein during extracorporeal life support procedures.

FDA Devices Moderate Oct 24, 2018

Reinforced Dual Lumen Cannula, 19Fr., REF: VV19F, Sterile EO Indications: The OriGen Reinforced Dual Lumen Cannula is indicated for use as a single cannula for both venous drainage and re-infusion of blood in the internal jugular vein during extracorporeal life support procedures.

FDA Devices Critical Nov 1, 2017

The OriGen Reinforced Dual Lumen catheter (RDLC) is a duel lumen catheter with a wire reinforcement layer on the tip of the device. A thin sheath is used to cover and secure the wire layer and is heat shrunk into a permanent position.

FDA Devices Critical Apr 29, 2015

OriGen BIOMEDICAL VV13F Reinforced Dual Lumen Catheter STERILE DISPOSABLE: DO NOT RE-USE Manufactured by: OriGen Biomedical. OriGene VV13F Reinforced Dual Lumen Catheter indicated for use as a single cannula for both venous drainage and re-infusion of blood in the internal jugular vein during extracorporeal life support procedures of six hours or less.

OriGen Biomedical, Inc. holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (19 here).

Similar medical devices volume

Nearest multi-notice firms in the same narrow category lane.

Frequently Asked Questions

How many federal recall notices name OriGen Biomedical, Inc.?
PlainRecalls indexes 19 distinct federal recall events naming OriGen Biomedical, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does OriGen Biomedical, Inc. sit among other recalling firms?
OriGen Biomedical, Inc. ranks #857 of 14,151 by distinct recall-event count among 14,151 firms in this archive (94th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of OriGen Biomedical, Inc.'s notices?
FDA Devices accounts for 19 of this firm's 19 indexed notices.
What product category dominates OriGen Biomedical, Inc.'s filing book?
Filings for OriGen Biomedical, Inc. span 1 product category, led by medical devices. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous?
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
OriGen Biomedical, Inc.: 19 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Devices). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming OriGen Biomedical, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026